Loss of UHRF1 strongly impaired 3D growth of NSCLC cells expressing oncogenic KRAS while having little effect in KRAS wild-type cells (H1437) or in the non-transformed HBEC line (NL20 cells) (Fig. 2b). This evidence concerns the gene KRAS and non-small cell lung carcinoma.